Adherence to oral anticoagulant therapy in patients with atrial fibrillation
- 1 February 2017
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 117 (02), 209-218
- https://doi.org/10.1160/th16-10-0757
Abstract
Oral anticoagulation is pivotal in the management of thromboembolic risk in non-valvular atrial fibrillation (NVAF) patients. Effective anticoagulation is important to avoid major adverse events and medication adherence is central to achieve good anticoagulation control. Non-vitamin K antagonist oral anticoagulants (NOACs) are as effective and safe as vitamin K antagonist (VKAs) in NVAF patients. Due to the absence of routine anticoagulation monitoring with NOACs treatment, concerns have been raised about patient’s adherence to NOACs and real-life data demonstrates variability in adherence and persistence. A multi-level approach, including patients’ preferences, factors determining physicians’ prescribing habits and healthcare system infrastructure and support, is warranted to improve initiation and adherence of anticoagulants. Adherence to NOACs is paramount to achieve a clinical benefit. Implementation of educational programs and easy-to-use tools to identify patients most likely to be non-adherent to NOACs, are central issues in improving the quality of NVAF anticoagulation management. Note: The review process for this manuscript was fully handled by C. Weber, Editor in Chief. * Both authors equally contributed to the paper as first authors. # Joint senior authors.This publication has 99 references indexed in Scilit:
- Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised TrialPLOS ONE, 2013
- Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories: A Systematic Literature Review and Meta-AnalysisDrugs, 2013
- Apixaban versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2011
- Warfarin Discontinuation After Starting Warfarin for Atrial FibrillationCirculation: Cardiovascular Quality and Outcomes, 2010
- An integrated chronic care program for patients with atrial fibrillation: Study protocol and methodology for an ongoing prospective randomised controlled trialInternational Journal of Nursing Studies, 2010
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)European Heart Journal, 2010
- Patient Attitudinal and Behavioral Factors Associated with Warfarin Non-adherence at Outpatient Anticoagulation ClinicsInternational Journal of Behavioral Medicine, 2009
- Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial FibrillationCirculation: Cardiovascular Quality and Outcomes, 2008
- Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysisBMJ, 2006
- Adherence to MedicationThe New England Journal of Medicine, 2005